A sodium channel blocker and class Ib antiarrhythmic agent
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Mexiletine (hydrochloride)

Item No. 23782

Technical Information
Formal Name
1-(2,6-dimethylphenoxy)-2-propanamine, monohydrochloride
CAS Number
5370-01-4
Synonyms
  • Ko 1173
Molecular Formula
C11H17NO • HCl
Formula Weight
Purity
≥98%
Formulation
A solid
DMF: 10 mg/mLDMSO: 10 mg/mLEthanol: 30 mg/mLPBS (pH 7.2): 10 mg/mL
SMILES
CC1=CC=CC(C)=C1OCC(C)N.Cl
InChi Code
InChI=1S/C11H17NO.ClH/c1-8-5-4-6-9(2)11(8)13-7-10(3)12;/h4-6,10H,7,12H2,1-3H3;1H
InChi Key
NFEIBWMZVIVJLQ-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Product Description

    Mexiletine is a voltage-gated sodium channel blocker and class Ib antiarrhythmic agent that preferentially binds to open/inactive channels.1 It inhibits aconitine-induced dysrhythmias in mice with ED50 values of 57 and 107 mg/kg for intraperitoneal and oral administration, respectively.2 Mexiletine decreases or inhibits conduction across the Purkinje fiber-muscle junction, shortens action potential duration, and decreases the refractory period when used at concentrations less than 5 µg/ml in isolated canine Purkinje fiber and ventricular muscle preparations.3

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Roselli, M., Carocci, A., Budriesi, R., et alSynthesis, antiarrhythmic activity, and toxicological evaluation of mexiletine analogues. Eur. J. Med. Chem. 121(1), 300-307 (2016).

    2. Winslow, E. Evaluation of antagonism of aconitine-induced dysrhythmias in mice as a method of detecting and assessing antidysrhythmic activity. Br. J. Pharmacol. 71(2), 615-622 (1980).

    3. Iwamura, N., Shimizu, T., Toyoshima, H., et alElectrophysiological actions of a new antiarrhythmic agent on isolated preparations of the canine purkinje fiber and ventricular muscle. Cardiology 61(5-6), 329-340 (1976).